{"id":"NCT04726969","sponsor":"Jennifer Keiser","briefTitle":"Efficacy and Safety of MOX/ALB Co-administration","officialTitle":"Efficacy and Safety of Combination Moxidectin and Albendazole, Ivermectin and Albendazole and Albendazole Alone in Adolescents and Adults Infected With Trichuris Trichiura: a Randomized Controlled Trial","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2021-06-15","primaryCompletion":"2021-09-09","completion":"2021-09-09","firstPosted":"2021-01-27","resultsPosted":"2023-02-02","lastUpdate":"2024-01-24"},"enrollment":255,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Trichuriasis","Ascariasis","Hookworm Infections"],"interventions":[{"type":"DRUG","name":"Moxidectin 2 mg Oral Tablet","otherNames":[]},{"type":"DRUG","name":"Albendazole 400 mg Oral Tablet","otherNames":["Zentel®"]},{"type":"DRUG","name":"Ivermectin 3 mg Oral Tablet","otherNames":["Stromectol®"]}],"arms":[{"label":"Arm A: moxidectin and albendazole","type":"EXPERIMENTAL"},{"label":"Arm B: albendazole","type":"PLACEBO_COMPARATOR"},{"label":"Arm C: ivermectin and albendazole","type":"EXPERIMENTAL"}],"summary":"This study is a double-blind randomized controlled superiority trial aiming at providing evidence on the efficacy and safety of co-administered moxidectin and albendazole versus albendazole monotherapy (standard of care) against whipworm (T. trichiura) infections in adolescents and adults (12-60 years) in Côte d'Ivoire. One arm of patients will be treated with albendazole-ivermectin.\n\nAs measure of efficacy of the treatment the cure rate (percentage of egg-positive subjects at baseline who become egg-negative after treatment) will be determined 14-21 days post-treatment.","primaryOutcome":{"measure":"Cure Rate (CR) of Moxidectin/Albendazole Combination Therapy Compared to Albendazole Monotherapy Against T. Trichiura","timeFrame":"14-21 days after treatment","effectByArm":[{"arm":"Arm A: Moxidectin and Albendazole","deltaMin":15.3,"sd":null},{"arm":"Arm B: Albendazole","deltaMin":13.4,"sd":null}],"pValues":[]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":9},"locations":{"siteCount":1,"countries":["Côte d’Ivoire"]},"refs":{"pmids":["37357904"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":85},"commonTop":["Abdominal pain","Headache","Itching","Symptoms related to immune system activation","Diarrhea"]}}